Company Data

Imugene Ltd.

Fundamental Analysis:

Imugene Ltd.

Imugene Ltd.
Fundamental Analysis:
Ticker
IUGNF
Current Price
$0.1294 -7.57%
Market Cap
$811.1M
Price Target
Refer to Report
Volume
201.2K
52wk Range
$0.0837 - $0.469
Advanced Market Data

Overview

Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.